To include your compound in the COVID-19 Resource Center, submit it here.

Lexiva infectious data

Data from the APV30005 study in 211 patients who had completed the SOLO Phase III

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE